LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Travere Therapeutics (NASDAQ: TVTX)

Follow NASDAQ:TVTX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
11/04/2025
Buy
$8.93
6,250
$56K
115,660
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
11/04/2025
Buy
$22.40
12,500
$280K
109,410
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
11/04/2025
Buy
$27.50
15,000
$413K
96,910
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
11/04/2025
Buy
$26.88
17,500
$470K
81,910
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
11/04/2025
Buy
$25.25
10,000
$253K
64,410
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
11/04/2025
Sell
$36.00
67,115
$2.416M
48,545
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
11/04/2025
Sell
$8.93
6,250
$56K
18,750
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
11/04/2025
Sell
$22.40
12,500
$280K
7,500
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
11/04/2025
Sell
$27.50
15,000
$413K
2,500
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
11/04/2025
Sell
$26.88
17,500
$470K
0
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
11/04/2025
Sell
$25.25
10,000
$253K
0
NASDAQ TVTX Travere Therapeutics
Coughlin Timothy / director
10/31/2025
Buy
$17.44
10,000
$174K
73,500
NASDAQ TVTX Travere Therapeutics
Coughlin Timothy / director
10/31/2025
Buy
$16.33
8,000
$131K
63,500
NASDAQ TVTX Travere Therapeutics
Coughlin Timothy / director
10/31/2025
Sell
$35.03
18,000
$631K
55,500
NASDAQ TVTX Travere Therapeutics
Coughlin Timothy / director
10/31/2025
Sell
$16.33
8,000
$131K
0
NASDAQ TVTX Travere Therapeutics
Coughlin Timothy / director
10/31/2025
Sell
$17.44
10,000
$174K
0
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: CHIEF COMMERCIAL OFFICER
10/31/2025
Sell
$35.00
5,591
$196K
119,071
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
10/28/2025
Buy
$15.46
92,872
$1.436M
512,045
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
10/29/2025
Buy
$15.46
27,128
$419K
446,301
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
10/28/2025
Sell
$30.38
92,872
$2.821M
419,173
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
10/29/2025
Sell
$30.12
27,128
$817K
419,173
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
10/28/2025
Sell
$15.46
92,872
$1.436M
207,128
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
10/29/2025
Sell
$15.46
27,128
$419K
180,000
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: CHIEF COMMERCIAL OFFICER
10/28/2025
Sell
$30.00
2,662
$80K
124,662

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous